OpenBilldrug price receipt

NADAC week of 2026-10-14

TICAGRELOR 90 MG TABLET

For 30 tablets

Pharmacies pay

$7.59 filed

30 × $0.25291 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$13.73 estimated

$7.59 + $1.14 (15%) + $5.00 fee per fill = $13.73

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TICAGRELOR 90 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ticagrelor.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 16 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Inc. and AiPing Pharmaceutical, Inc.

FDA’s Established Pharmacologic Class for it is P2Y12 Platelet Inhibitor.

The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 19 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $7.59 for 30 tablets (30 × $0.25291 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 16 labelers

LabelerNDCsPharmacies pay per unit
AiPing Pharmaceutical, Inc2$0.25291 per EA filed
Ascend Laboratories, LLC2$0.25291 per EA filed
Novadoz Pharmaceuticals LLC2$0.25291 per EA filed
Alembic Pharmaceuticals Inc.1$0.25291 per EA filed
American Health Packaging1$0.25291 per EA filed
Apotex Corp.1$0.25291 per EA filed
AvPAK1$0.25291 per EA filed
BIONPHARMA INC.1$0.25291 per EA filed
Dr. Reddys Laboratories Inc1$0.25291 per EA filed
Exelan Pharmaceuticals, Inc1$0.25291 per EA filed
Hisun Pharmaceuticals USA, Inc.1$0.25291 per EA filed
Macleods Pharmaceuticals Limited1$0.25291 per EA filed
Mylan Pharmaceuticals Inc.1$0.25291 per EA filed
Oryza Pharmaceuticals, Inc.1$0.25291 per EA filed
ScieGen Pharmaceuticals INC1$0.25291 per EA filed
Teva Pharmaceuticals, Inc.1$0.25291 per EA filed
Not listed as a package in the FDA directory2$0.25291 per EA filed
All 21 NDCs, with labeler and price
  • 00378-2215-91 · Mylan Pharmaceuticals Inc. · $0.25291 per EA · eff. 2026-09-23 filed
  • 00480-2695-06 · Teva Pharmaceuticals, Inc. · $0.25291 per EA · eff. 2026-09-23 filed
  • 11788-0158-01 · AiPing Pharmaceutical, Inc · $0.25291 per EA · eff. 2026-09-23 filed
  • 11788-0158-60 · AiPing Pharmaceutical, Inc · $0.25291 per EA · eff. 2026-09-23 filed
  • 33342-0432-09 · Macleods Pharmaceuticals Limited · $0.25291 per EA · eff. 2026-09-23 filed
  • 42658-0115-03 · Hisun Pharmaceuticals USA, Inc. · $0.25291 per EA · eff. 2026-09-23 filed
  • 43598-0480-60 · Dr. Reddys Laboratories Inc · $0.25291 per EA · eff. 2026-09-23 filed
  • 50228-0522-60 · ScieGen Pharmaceuticals INC · $0.25291 per EA · eff. 2026-09-23 filed
  • 50268-0826-01 · AvPAK · $0.25291 per EA · eff. 2026-09-23 filed
  • 50268-0826-11 · not listed as a package in the FDA directory · $0.25291 per EA · eff. 2026-09-23 filed
  • 60505-4452-06 · Apotex Corp. · $0.25291 per EA · eff. 2026-09-23 filed
  • 60687-0928-11 · not listed as a package in the FDA directory · $0.25291 per EA · eff. 2026-09-23 filed
  • 60687-0928-57 · American Health Packaging · $0.25291 per EA · eff. 2026-09-23 filed
  • 62332-0241-60 · Alembic Pharmaceuticals Inc. · $0.25291 per EA · eff. 2026-09-23 filed
  • 67877-0491-05 · Ascend Laboratories, LLC · $0.25291 per EA · eff. 2026-09-23 filed
  • 67877-0491-60 · Ascend Laboratories, LLC · $0.25291 per EA · eff. 2026-09-23 filed
  • 69452-0509-17 · BIONPHARMA INC. · $0.25291 per EA · eff. 2026-09-23 filed
  • 72205-0368-60 · Novadoz Pharmaceuticals LLC · $0.25291 per EA · eff. 2026-09-23 filed
  • 72205-0368-91 · Novadoz Pharmaceuticals LLC · $0.25291 per EA · eff. 2026-09-23 filed
  • 72516-0018-06 · Oryza Pharmaceuticals, Inc. · $0.25291 per EA · eff. 2026-09-23 filed
  • 76282-0550-60 · Exelan Pharmaceuticals, Inc · $0.25291 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name ticagrelor with TICAGRELOR 90 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BRILINTA 60 MG TABLET
brand · tablet
$7.41915 per EA filed
eff. 2026-09-23
$7.26012 per EA filed
Part D 2024 average
BRILINTA 90 MG TABLET
brand · tablet
$7.42045 per EA filed
eff. 2026-09-23
$7.26012 per EA filed
Part D 2024 average
TICAGRELOR 60 MG TABLET
generic · tablet, film coated / tablet
$0.28214 per EA filed
eff. 2026-09-23
We don’t know yet
TICAGRELOR 90 MG TABLET this page
generic · tablet, film coated / tablet
$0.25291 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 21 NDCs’ NADAC prices is $0.25291 per EA filed.

Of the 8 other products in FDA’s P2Y12 Platelet Inhibitor class priced per EA, 7 have a higher middle NADAC price and 1 a lower one. The one in the middle is TICAGRELOR 60 MG TABLET, at $0.28214 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.